Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas: Clinical and therapeutic features of 24 localized patients

P. L. Zinzani, M. Magagnoli, S. Ascani, P. Ricci, V. Poletti, F. Gherlinzoni, G. Frezza, M. Bendandi, C. Stefanetti, E. Merla, S. Pileri, S. Tura

Research output: Contribution to journalArticle

Abstract

Background: Peripheral B-cell lymphoma of the marginal zone (MALT, low- grade), presenting as localized, extranodal disease, usually affects the elderly. The gastrointestinal tract is the most frequently involved extranodal location, representing 70% of all MALT lymphomas. Recently, numerous other extranodal sites involved by MALT lymphomas have also been described. Patients and methods: From January 1990 to October 1995, 24 patients with untreated nongastrointestinal low-grade MALT lymphoma were submitted to treatments ranging from the local approach of radiotherapy and local α-interferon (α-IFN) administration to chemotherapy. The tumours were located in the lung (seven cases), conjunctiva (four cases), lachrymal gland and orbital soft tissue (four cases), salivary glands (three cases), skin (three cases), breast (two cases), and thyroid (one case). All patients had low-grade stage IE tumours. Results: Chemotherapy was administered in 11 patients (six with lung, three with salivary gland, one with breast, and one with thyroid locations); radiation therapy was employed in seven patients (three with lachrymal gland, three with skin, and one with breast locations); local α-IFN administration was administered in five patients (four with conjunctival, and one with lachrymal gland sites); and surgery was employed in one patient with a lung tumour. All patients achieved complete remissions; three local recurrences and two relapses in other sites were observed. The global five-year survival rate was 100% with a relapse-free survival rate of 79%. Conclusions: These data confirm the significant efficacy of different therapeutic approaches to specific sites inbes obtaining a good remission rate for nongastrointestinal localized low-grade MALT lymphomas.

Original languageEnglish
Pages (from-to)883-886
Number of pages4
JournalAnnals of Oncology
Volume8
Issue number9
DOIs
Publication statusPublished - Sep 1997

Fingerprint

Marginal Zone B-Cell Lymphoma
Breast
Therapeutics
Salivary Glands
Recurrence
Non-Hodgkin's Lymphoma
Lung
Thyroid Gland
Radiotherapy
Survival Rate
Drug Therapy
Neoplasms
Skin
Conjunctiva
Lymphoid Tissue
Interferons
Gastrointestinal Tract
Mucous Membrane

Keywords

  • α-Interferon
  • Low-grade MALT lymphoma
  • Non-gastrointestinal
  • Radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas : Clinical and therapeutic features of 24 localized patients. / Zinzani, P. L.; Magagnoli, M.; Ascani, S.; Ricci, P.; Poletti, V.; Gherlinzoni, F.; Frezza, G.; Bendandi, M.; Stefanetti, C.; Merla, E.; Pileri, S.; Tura, S.

In: Annals of Oncology, Vol. 8, No. 9, 09.1997, p. 883-886.

Research output: Contribution to journalArticle

Zinzani, PL, Magagnoli, M, Ascani, S, Ricci, P, Poletti, V, Gherlinzoni, F, Frezza, G, Bendandi, M, Stefanetti, C, Merla, E, Pileri, S & Tura, S 1997, 'Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas: Clinical and therapeutic features of 24 localized patients', Annals of Oncology, vol. 8, no. 9, pp. 883-886. https://doi.org/10.1023/A:1008278725106
Zinzani, P. L. ; Magagnoli, M. ; Ascani, S. ; Ricci, P. ; Poletti, V. ; Gherlinzoni, F. ; Frezza, G. ; Bendandi, M. ; Stefanetti, C. ; Merla, E. ; Pileri, S. ; Tura, S. / Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas : Clinical and therapeutic features of 24 localized patients. In: Annals of Oncology. 1997 ; Vol. 8, No. 9. pp. 883-886.
@article{1de90ba9ce714224ae67893b5838c8a3,
title = "Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas: Clinical and therapeutic features of 24 localized patients",
abstract = "Background: Peripheral B-cell lymphoma of the marginal zone (MALT, low- grade), presenting as localized, extranodal disease, usually affects the elderly. The gastrointestinal tract is the most frequently involved extranodal location, representing 70{\%} of all MALT lymphomas. Recently, numerous other extranodal sites involved by MALT lymphomas have also been described. Patients and methods: From January 1990 to October 1995, 24 patients with untreated nongastrointestinal low-grade MALT lymphoma were submitted to treatments ranging from the local approach of radiotherapy and local α-interferon (α-IFN) administration to chemotherapy. The tumours were located in the lung (seven cases), conjunctiva (four cases), lachrymal gland and orbital soft tissue (four cases), salivary glands (three cases), skin (three cases), breast (two cases), and thyroid (one case). All patients had low-grade stage IE tumours. Results: Chemotherapy was administered in 11 patients (six with lung, three with salivary gland, one with breast, and one with thyroid locations); radiation therapy was employed in seven patients (three with lachrymal gland, three with skin, and one with breast locations); local α-IFN administration was administered in five patients (four with conjunctival, and one with lachrymal gland sites); and surgery was employed in one patient with a lung tumour. All patients achieved complete remissions; three local recurrences and two relapses in other sites were observed. The global five-year survival rate was 100{\%} with a relapse-free survival rate of 79{\%}. Conclusions: These data confirm the significant efficacy of different therapeutic approaches to specific sites inbes obtaining a good remission rate for nongastrointestinal localized low-grade MALT lymphomas.",
keywords = "α-Interferon, Low-grade MALT lymphoma, Non-gastrointestinal, Radiotherapy",
author = "Zinzani, {P. L.} and M. Magagnoli and S. Ascani and P. Ricci and V. Poletti and F. Gherlinzoni and G. Frezza and M. Bendandi and C. Stefanetti and E. Merla and S. Pileri and S. Tura",
year = "1997",
month = "9",
doi = "10.1023/A:1008278725106",
language = "English",
volume = "8",
pages = "883--886",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "9",

}

TY - JOUR

T1 - Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas

T2 - Clinical and therapeutic features of 24 localized patients

AU - Zinzani, P. L.

AU - Magagnoli, M.

AU - Ascani, S.

AU - Ricci, P.

AU - Poletti, V.

AU - Gherlinzoni, F.

AU - Frezza, G.

AU - Bendandi, M.

AU - Stefanetti, C.

AU - Merla, E.

AU - Pileri, S.

AU - Tura, S.

PY - 1997/9

Y1 - 1997/9

N2 - Background: Peripheral B-cell lymphoma of the marginal zone (MALT, low- grade), presenting as localized, extranodal disease, usually affects the elderly. The gastrointestinal tract is the most frequently involved extranodal location, representing 70% of all MALT lymphomas. Recently, numerous other extranodal sites involved by MALT lymphomas have also been described. Patients and methods: From January 1990 to October 1995, 24 patients with untreated nongastrointestinal low-grade MALT lymphoma were submitted to treatments ranging from the local approach of radiotherapy and local α-interferon (α-IFN) administration to chemotherapy. The tumours were located in the lung (seven cases), conjunctiva (four cases), lachrymal gland and orbital soft tissue (four cases), salivary glands (three cases), skin (three cases), breast (two cases), and thyroid (one case). All patients had low-grade stage IE tumours. Results: Chemotherapy was administered in 11 patients (six with lung, three with salivary gland, one with breast, and one with thyroid locations); radiation therapy was employed in seven patients (three with lachrymal gland, three with skin, and one with breast locations); local α-IFN administration was administered in five patients (four with conjunctival, and one with lachrymal gland sites); and surgery was employed in one patient with a lung tumour. All patients achieved complete remissions; three local recurrences and two relapses in other sites were observed. The global five-year survival rate was 100% with a relapse-free survival rate of 79%. Conclusions: These data confirm the significant efficacy of different therapeutic approaches to specific sites inbes obtaining a good remission rate for nongastrointestinal localized low-grade MALT lymphomas.

AB - Background: Peripheral B-cell lymphoma of the marginal zone (MALT, low- grade), presenting as localized, extranodal disease, usually affects the elderly. The gastrointestinal tract is the most frequently involved extranodal location, representing 70% of all MALT lymphomas. Recently, numerous other extranodal sites involved by MALT lymphomas have also been described. Patients and methods: From January 1990 to October 1995, 24 patients with untreated nongastrointestinal low-grade MALT lymphoma were submitted to treatments ranging from the local approach of radiotherapy and local α-interferon (α-IFN) administration to chemotherapy. The tumours were located in the lung (seven cases), conjunctiva (four cases), lachrymal gland and orbital soft tissue (four cases), salivary glands (three cases), skin (three cases), breast (two cases), and thyroid (one case). All patients had low-grade stage IE tumours. Results: Chemotherapy was administered in 11 patients (six with lung, three with salivary gland, one with breast, and one with thyroid locations); radiation therapy was employed in seven patients (three with lachrymal gland, three with skin, and one with breast locations); local α-IFN administration was administered in five patients (four with conjunctival, and one with lachrymal gland sites); and surgery was employed in one patient with a lung tumour. All patients achieved complete remissions; three local recurrences and two relapses in other sites were observed. The global five-year survival rate was 100% with a relapse-free survival rate of 79%. Conclusions: These data confirm the significant efficacy of different therapeutic approaches to specific sites inbes obtaining a good remission rate for nongastrointestinal localized low-grade MALT lymphomas.

KW - α-Interferon

KW - Low-grade MALT lymphoma

KW - Non-gastrointestinal

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=9844263374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9844263374&partnerID=8YFLogxK

U2 - 10.1023/A:1008278725106

DO - 10.1023/A:1008278725106

M3 - Article

C2 - 9358939

AN - SCOPUS:9844263374

VL - 8

SP - 883

EP - 886

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 9

ER -